Voyager Therapeutics (VYGR) EBIT Margin Growth (5y) (2020 - 2026)
Voyager Therapeutics (VYGR) EBIT Margin Growth (5y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Voyager Therapeutics |
222.52 Mn |
81.04 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-77,376.00 |
| Dec 31, 2025 |
16,830.00 |
| Sep 30, 2025 |
-30,004.00 |
| Jun 30, 2025 |
-67,301.00 |
| Mar 31, 2025 |
-39,850.00 |
| Dec 31, 2024 |
-56,569.00 |
| Sep 30, 2024 |
3,120.00 |
| Jun 30, 2024 |
-7,070.00 |
| Mar 31, 2024 |
48,066.00 |
| Dec 31, 2023 |
110,919.00 |
| Sep 30, 2023 |
36,843.00 |
| Jun 30, 2023 |
47,893.00 |
| Mar 31, 2023 |
232,083.00 |
| Dec 31, 2022 |
177,927.00 |
| Sep 30, 2022 |
206,956.00 |
| Jun 30, 2022 |
-113,648.00 |
| Mar 31, 2022 |
-204,782.00 |
| Dec 31, 2021 |
60,638.00 |
| Sep 30, 2021 |
-138,325.00 |
| Jun 30, 2021 |
-184,794.00 |
